LISINOPRIL TABLETS USP 40MG WILL BE CHANGING NDC’S EFFECTIVE JUNE 24, 2021.
Impact of change: Tablet weight reduction of 40mg tablet from 220mg to 162mg. This change has been approved by the FDA. There is no change to the following: tablet color, shape, imprint, ingredients and excipients. This product should be considered genuine and this change is not expected to affect efficacy or safety of the product. The amount of active ingredient has not changed; thus, no change in effect is anticipated.
The changes are outlined below: